Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPS in Hyperkalemia
NCT01866709Phase 4Terminated
- Sponsor
- ZS Pharma
- Start
- May 2013
- Primary completion
- Jul 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of sodium polystyrene sulfonate in hyperkalemia, sponsored by ZS Pharma. Started May 2013; status: terminated.
02
Drugs
sodium polystyrene sulfonate
03
Conditions
hyperkalemia
Beyond the preview
Go deeper on NCT01866709.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01866709.